These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 19681019
1. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels. Cunha BA. Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019 [No Abstract] [Full Text] [Related]
2. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B. Am J Respir Crit Care Med; 2006 Jul 01; 174(1):84-93. PubMed ID: 16603606 [Abstract] [Full Text] [Related]
3. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia. Jereb M, Kotar T. Wien Klin Wochenschr; 2006 Apr 01; 118(5-6):170-4. PubMed ID: 16773483 [Abstract] [Full Text] [Related]
4. [Community-acquired pneumonia and procalcitonin, an opportunity to improve?]. Tudela P, Mòdol JM. Med Clin (Barc); 2014 Apr 07; 142(7):303-5. PubMed ID: 24183120 [No Abstract] [Full Text] [Related]
11. [Usefulness of procalcitonin and C-reactive protein in community-acquired pneumonia in the emergency department]. Julián-Jiménez A, Palomo de Los Reyes MJ, Sentenac JG, Aguilar J. Enferm Infecc Microbiol Clin; 2010 Nov 12; 28(9):666-7. PubMed ID: 20846753 [No Abstract] [Full Text] [Related]
16. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, Nicholson KG, Brightling CE. Chest; 2011 Jun 12; 139(6):1410-1418. PubMed ID: 21030489 [Abstract] [Full Text] [Related]